Western blot analysis and immunohistochemistry examination conducted by Zhang et al. [32] showed decreased liver expression of SIRT1, QKI5, FOXO1 and PPARα in the tested NAFLD mice when compared to the control group. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.